Table 2.
Antibody differences between vaccine types.
| SARS CoV-2 Naïve | ||||||||
|---|---|---|---|---|---|---|---|---|
| Vaccine Median (IQR) | BNT162b2 mRNA (n=289) | mRNA-1273 (n=65) | Gam-COVID-Vac (n=213) | Coronavac (n=582) | ChAdOx1-S (n=666) | Ad5-nCoV Cansino (n=19) | Ad26.COV2(n=31) | p-value |
| Basal | 3.8 (0) | 3.8 (26.6) | 3.8 (0) | 3.8(0.9) | 3.8 (0) | 3.8 (0) | 3.8 (13.5) | p<0.005 |
| After First Dose | 78.1 (55.0) | 175.5 (76.7) | 22.1 (44.5) | 5.59 (8.0) | 19.9 (39.6) | 43.45 (55.9) | 42.6 (57.5) | p<0.001 |
| After Second Dose | 998 (1241.0) | 1875 (1190.0) | 501 (1453.7) | 109 (97.6) | 140.5 (199.5) | NA | NA | p<0.001 |
| SARS CoV-2 Positive | ||||||||
| Basal | 66.9 (130.8) | 59.3 (67.9) | 59.8 (157.3) | 72.4 (119.0) | 61.9 (134.8) | 141.0 (175.2) | 24 (66.7) | p<0.001 |
| After First dose | 2500.0 (3080.0) | 5920.0 (4705.0) | 400.0 (3252.0) | 264.5 (422.7) | 1025.0 (2489.0) | 182.0 (3734.6) | 606.5 (23.69.0) | p<0.001 |
| After Second Dose | 2630.0 (2672.5) | 4950.0 (3060) | 3620 (5356) | 279(337) | 1020 (1538) | NA | NA | p<0.001 |
BNT162b2 mRNA, mRNA-1273 and Gam-COVID-Vac showed higher antibody levels after first and second dose.
*Kruskal-Wallis test was performed for comparison, p<0.05 was considered statistically significant. NA, does not apply.